Neimeth Launches Co- Amoxiclav – Anti-Biotic
Neimeth International Pharmaceuticals Plc recently increased her Portfolio of diverse therapeutic entities with the introduction of Co- Amoxiclav, a potent antibiotic.
Co-Amoxiclav is a combination of Amoxicillin Trihydrate and Clavulanate Potassium.
Amoxicillin and Clavulanate are indicated for the short term treatment of common bacterial infections such as, Upper Respiratory Tract Infections […]